Charles Goodwin | President and Chief Executive Officer |
Tara Semb | Chief Financial Officer |
Matthew Hewitt | Craig-Hallum Capital Group LLC |
Matthew O’Brien | Piper Jaffray & Co. |
David Ciruli | JMP Securities |
Kyle Bauser | Dougherty & Company LLC |
Good afternoon, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal Year 2019 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in a listen-only mode. At the end of the company’s prepared remarks, we will conduct a question-and-answer session. Please note that this conference call is being recorded and that the recording will be available on the company’s website for replay shortly.
Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the risk factors section of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, as well as our most recent 10-Q filing.